Antibiotic Use and Survival in Patients With Late-Stage NSCLC Treated With Chemoimmunotherapy

Antibiotic Use and Survival in Patients With Late-Stage NSCLC Treated With Chemoimmunotherapy

Introduction: Immunotherapy has improved survival in patients with advanced NSCLC. Efficacy may decrease when patients are treated with antibiotics, possibly due to gut microbiome disruption, but few studies have investigated this using real-world, patient-level populations in the United States. Met...

Full description

Saved in:
Bibliographic Details
Main Authors: Emanuela Taioli, MD, PhD, Raja M. Flores, MD, Arwa Abdelhamid, MPH, Matthew Untalan, MPH, Tara Ivic-Pavlicic, MPH, Stephanie Tuminello, PhD, MPH
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:JTO Clinical and Research Reports
Subjects:
Immunotherapy
Chemoimmunotherapy
Immune checkpoint inhibitors
Antibiotics
NSCLC
Survival
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364324000808
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2666364324000808

Similar Items